ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SMMT Summit Therapeutics Inc

9.48
0.01 (0.11%)
Pre Market
Last Updated: 11:02:21
Delayed by 15 minutes
Name Symbol Market Type
Summit Therapeutics Inc NASDAQ:SMMT NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.01 0.11% 9.48 9.47 9.76 1,020 11:02:21

ADRs End Higher; Pharmaceuticals Trade Actively

22/06/2017 10:44pm

Dow Jones News


Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Summit Therapeutics Charts.
   By Anne Steele 
 

Prices of International stocks trading in New York closed higher on Thursday.

The BNY Mellon index of American depositary receipts rose 0.4% to 140.07. The European index increased 0.3% to 133.16, the Asian index improved 0.3% to 159.79, the Latin American index climbed 1% to 212.84 and the emerging markets index increased 0.3% to 287.26.

Pharmaceutical companies were among those trading actively.

ADRs of Teva Pharmaceutical Industries Ltd. (TEVA.TV, TEVA) ended 4.7% higher at $32.52 after Mizuho raised its rating to neutral from underperform.

ADRs of Novartis AG (NVS, NOVN.EB) rose 4.6% to $86.34 after the company said a drug that it sells for various immunology conditions reduced the risk of serious heart problems in patients who have had a heart attack and who suffer inflammation related to fat build-up in the arteries.

ADRs of Summit Therapeutics PLC (SMMT, SUMM.LN) climbed 3.7% to $11.49 after the company presented data from two early-stage clinical trials of its Duchenne muscular dystrophy drug ezutromid.

 

Write to Anne Steele at anne.steele@wsj.com.

 

(END) Dow Jones Newswires

June 22, 2017 17:29 ET (21:29 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Summit Therapeutics Chart

1 Year Summit Therapeutics Chart

1 Month Summit Therapeutics Chart

1 Month Summit Therapeutics Chart

Your Recent History

Delayed Upgrade Clock